Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Melanotan II with light therapy for vitiligo
Official title: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Melanotan II (Synthetic Cyclic Melanocortin Receptor Agonist) as an Adjunct to Narrowband UV-B Phototherapy in Adults With Stable Nonsegmental Vitiligo
Status: Recruiting now
Description:
Hudson Biotech plans to enroll about 60 participants. Melanotan II is an unapproved synthetic hormone-like compound that stimulates melanin production. Combined with UVB light, it may increase skin pigmentation. Possible effects include nausea, flushing, appetite changes, darkening of skin or moles, and other risks that are not fully known. People ages 18 to 65 may qualify. The study is recruiting at one listed site in China.
Start date: February 02, 2026
Completion date: February 17, 2028
Organizer: Hudson Biotech
Contact: Seni S Lu, Phd
Tel.: +86 13076790030
Email: Seni-Lu@beijing-biotech.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Shall I try low-fat diet for my vitiligo?
The link between dietary fat and autoimmune diseases like vitiligo is a compelling yet complex puzzle that continues to intrigue scientists. While the conversation is ongoing, o...
- Does halo nevi affect vitiligo development?
Halo nevi (also known as Sutton's nevi) are characterized by a mole that's surrounded by a ring of depigmented or lighter skin. While both halo nevi and vitiligo involve the des...
- Pyrostegia venusta as a folk medicine for vitiligo?
Pyrostegia venusta, also known as “flame vine” or “cipó-de-são-joão,” is a neotropical evergreen vine native to Brazil. It thrives in fields, coastal areas, forest edges, and ro...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.